NCT06006247: Early Parkinson's Disease Monotherapy With CVN424
- State
- Completed
- Phase
- Phase 2
- People
- 64 taking part
- Started
- 11 Sep 2023
- Primary completion
- 30 Jan 2025
- Arms
- CVN424 150 mg
- Results
- Posted on the registry
- 23 Aug 2023: Trial registered
- 11 Sep 2023: Trial started
- 13 Feb 2025: Trial completed
- 23 Mar 2026: Trial results posted